The University of Chicago Header Logo

Connection

Raghu Mirmira to TYK2 Kinase

Back to Details
This is a "connection" page, showing publications Raghu Mirmira has written about TYK2 Kinase.
Raghu Mirmira
Connection Strength
0.184
TYK2 Kinase
  1. Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes. Diabetes Obes Metab. 2020 10; 22(10):1827-1836.
    View in: PubMed
    Score: 0.184
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.